You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

27 search results for: pediatric

Infographic

Pediatric EoE Disease Burden Infographic

5 min

Gastroenterology

Learn about pediatric EoE disease burden and why early identification is key for pediatric patients with EoE.

ADVENT On Air | Defining AD in <b>Pediatric</b> Patients

audio

ADVENT On Air | Defining AD in Pediatric Patients

15 min

Dermatology

Learn more about the journey of pediatric patients with AD in this conversation between Drs. Lisa Swanson and Weily Soong.

How Can Poor Lung Function Impact Asthma Burden in <b>Pediatric</b> Patients?

videoanimation

How Can Poor Lung Function Impact Asthma Burden in Pediatric Patients?

4 min

Pulmonology

Learn about the importance of lung function assessment in pediatric asthma patients.

ADVENT On Air | Clinical Perspective on <b>Pediatric</b> Patients With Atopic Dermatitis

audio

ADVENT On Air | Clinical Perspective on Pediatric Patients With Atopic Dermatitis

15 min

Dermatology

Listen to the expert perspectives of Drs. Lisa Swanson and Weily Soong on clinical considerations in pediatric patients with atopic dermatitis.

Type 2 Inflammation Mediates Severe Asthma in <b>Pediatric</b> Patients

expert video

Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients

19 min

Pulmonology

Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.

ADVENT On Air | What Is the Future Outlook for Remission in <b>Pediatric</b> Severe Asthma?

audio

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

24 min

Pulmonology

Join Drs. Len Bacharier and Sharon Dell as they highlight the natural course of pediatric asthma progression over time.

expert video

Keeping an Eye on Pediatric EoE

2 min

Gastroenterology

Global experts Prof. Arjan Bredenoord and Drs. Ikuo Hirano, Kathryn Peterson, and Evan Dellon discuss identification and assessment of pediatric EoE.

How Can FeNO Support the Management of <b>Pediatric</b> Asthma?

expert video

How Can FeNO Support the Management of Pediatric Asthma?

2 min

Pulmonology

Dr. Michael Blaiss discusses the importance of measuring FeNO in pediatric asthma patients.

Burdens Experienced by <b>Pediatric</b> Asthma Patients and Their Caregivers

expert video

Burdens Experienced by Pediatric Asthma Patients and Their Caregivers

3 min

Pulmonology

Drs. Michael Blaiss and Bob Geng discuss the burdens experienced by pediatric severe asthma patients and their caregivers.

FeNO: A Biomarker of Type 2 Inflammation in <b>Pediatric</b> Asthma Patients

Infographic

FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients

5 min

Pulmonology

Learn about the role of FeNO as a noninvasive test to identify type 2 inflammation in pediatric patients with asthma.

Expert Insights: Importance of Lung Function Assessment in <b>Pediatric</b> Asthma Patients

expert video

Expert Insights: Importance of Lung Function Assessment in Pediatric Asthma Patients

2 min

Pulmonology

Dr. Michael Blaiss describes the importance of lung function assessment in pediatric asthma management.

Importance of Lung Function Assessment in <b>Pediatric</b> Asthma Patients

videoanimation

Importance of Lung Function Assessment in Pediatric Asthma Patients

3 min

Pulmonology

Review the burden associated with lung function decline in pediatric patients with severe asthma and the value of clinical lung function assessments.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region